Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.43 USD | -0.05% | -18.55% | -93.58% |
16/04 | GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments | MT |
2023 | Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Sales 2021 | - | Sales 2022 | - | Capitalization | 3.7M 308M |
---|---|---|---|---|---|
Net income 2021 | -9M -750M | Net income 2022 | -7M -584M | EV / Sales 2021 | - |
Net cash position 2021 | 7.34M 612M | Net cash position 2022 | 3.78M 315M | EV / Sales 2022 | - |
P/E ratio 2021 |
-4.2
x | P/E ratio 2022 |
-0.42
x | Employees | 2 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
1 day | -0.05% | ||
Current month | -93.58% | ||
Current year | -93.58% |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.43 | -0.05% | 62,259 |
25/24/25 | 0.4302 | -1.65% | 25,078 |
24/24/24 | 0.4374 | -2.13% | 118,053 |
23/24/23 | 0.4469 | -2.85% | 143,359 |
22/24/22 | 0.46 | -12.86% | 394,531 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotes- Stock Market
- Equities
- GRI Stock